This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Factors to Impact Mid-America Apartment (MAA) in Q2 Earnings
by Zacks Equity Research
Higher demand for residential properties and a strategic redevelopment program will likely aid Mid-America Apartment (MAA) in Q2 amid elevated supply of new units in certain markets.
What's in the Cards for Arbor Realty's (ABR) Q2 Earnings?
by Zacks Equity Research
While solid origination volumes will support Arbor Realty's (ABR) Q2 results, anticipated year-over-year decline in its bottom line might thwart the company's quarterly performance.
CBRE Group (CBRE) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
CBRE Group (CBRE) will likely gain in Q2 from improving occupier outsourcing business and strategic acquisitions.
Key Factors Setting the Tone for HCP This Earnings Season
by Zacks Equity Research
Focus on life-science and MOB portfolio will likely enable HCP to witness decent growth in Q2. However, prevalent challenges in the senior housing market are a spoilsport.
Factors Setting the Tone for Welltower's (WELL) Q2 Earnings
by Zacks Equity Research
Demographic-driven demand boom and seniors-housing portfolio-strengthening initiatives will likely support Welltower's (WELL) Q2 results.
Factors to Impact Extra Space Storage (EXR) in Q2 Earnings
by Zacks Equity Research
While strong demand from boomer downsizing, and rise in renter households and businesses will aid Extra Space Storage (EXR) in Q2, pricing power has been flat in the face of ample supply.
What's in Store for Boston Properties' (BXP) Q2 Earnings?
by Zacks Equity Research
Sturdy employment growth rates, tightening U.S. office market fundamentals and healthy leasing activity will support Boston Properties' (BXP) Q2 performance.
UDR to Report Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Though UDR's Q2 results will likely reflect its efforts to enhance operating margins through innovative technological solutions and process enhancement, high deliveries of new units are a spoilsport.
Factors Setting the Tone for Vornado (VNO) in Q2 Earnings
by Zacks Equity Research
Although the retail real estate market displayed signs of recovery in Q2, Topshop's store closure at 608 Fifth Avenue is expected to unfavorably impact Vornado's (VNO) earnings.
What's in the Cards for Alexandria (ARE) This Earnings Season?
by Zacks Equity Research
Alexandria Real Estate Equities' (ARE) newly-developed projects will add incremental value, driving the company's Q2 leasing and revenue figures.
Can Ventas (VTR) Maintain its Beat Streak in Q2 Earnings?
by Zacks Equity Research
Ventas' (VTR) elevated and upgraded portfolio of medical office buildings (MOBs) likely to witness growth in service revenues during Q2.
Healthcare Realty (HR) Q1 FFO Meet Estimates
by Zacks Equity Research
Healthcare Realty (HR) delivered FFO and revenue surprises of 0.00% and -1.53%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Realty Completes MOB Buyouts in Potential Markets
by Zacks Equity Research
Healthcare Realty (HR) completes purchase of four properties, amid soaring popularity for medical-office buildings.
Healthcare Realty (HR) Prices Offering of 3.25M Common Stock
by Zacks Equity Research
Healthcare Realty's (HR) latest public offering of common stock will improve its financial flexibility and provide ample scope for deploying capital in accretive acquisitions.
Healthcare Realty (HR) Meets Q4 FFO Estimates
by Zacks Equity Research
Healthcare Realty (HR) delivered FFO and revenue surprises of 0.00% and -1.02%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Two Harbors Investment (TWO) Q4 Earnings: What to Expect?
by Zacks Equity Research
Two Harbors Investment's (TWO) capital deployments in mortgage servicing rights (MSR) and non-agency investment remain positives for the fourth quarter. Yet, rate volatility may impact its book value.
Why Trending Outpatient Care is a Boon for Healthcare REITs
by Devyani Chamria
Amid shift of care to low-cost setting, medical office buildings (MOBs) and outpatient facilities have been creating opportunities for healthcare REITs to park their money.
Healthcare Realty (HR) Q3 FFO Meet Estimates
by Zacks Equity Research
Healthcare Realty (HR) delivered FFO and revenue surprises of 0.00% and 1.80%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Realty (HR) Matches Q2 Earnings Estimates
by Zacks Equity Research
Healthcare Realty (HR) delivered earnings and revenue surprises of 0.00% and -0.71%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Rising Healthcare Spending Aid HCP This Earnings Season?
by Zacks Equity Research
HCP Q2 results likely to reflect benefit from shedding of Brookdale assets. However, rising interest rates remains a concern.
Healthcare Realty (HR) Calls to Redeem Senior Notes Due 2021
by Zacks Equity Research
Healthcare Realty Trust (HR) to pay $113.4 million for early redemption of $100 million of the $400 million senior notes due in 2021.
Healthcare Realty (HR) to Buy Medical Buildings in Atlanta
by Zacks Equity Research
Healthcare Realty Trust (HR) to raise funds through public offering primarily to pursue acquisitions in Atlanta.
Healthcare Realty Trust (HR) Enters Overbought Territory
by Zacks Equity Research
Healthcare Realty Trust Incorporated (HR) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Healthcare Realty's (HR) Q4 FFO Beats, Revenues Up Y/Y
by Zacks Equity Research
Healthcare Realty Trust Inc.'s (HR) fourth-quarter 2016 normalized FFO per share of 41 cents came a penny above the Zacks Consensus Estimate.